Netrio Survey Finds Mid-Market AI Adoption Is Widespread, but Readiness and Governance Gaps Remain
Censuswide survey of 401 U.S. mid-market enterprise IT leaders finds 82% already using AI in production, but only 26% say AI is scaled and governed enterprise-wide... Read more.
Wolfbox Launches HyperFlow 60D Tire Inflator, Built to Deliver 60 Minutes of Continuous Inflation
The new HyperFlow 60D brings sustained-duty output to a portable format, purpose-made for off-road use—trail rigs, overlanding vehicles and RV platforms running... Read more.
SAP NS2® announces general availability for solution suite deployed in FedRAMP+ Impact Level 5 cloud environment
HERNDON, Va., June 15, 2026 /PRNewswire/ — Today, SAP National Security Services (SAP NS2®) announced that the Defense Information and Systems Agency (DISA)... Read more.
Ideal Recovery and Absolute Recovery Announce Strategic Combination
Deal Facilitated by Viking Mergers & Acquisitions CHARLOTTE, N.C., June 15, 2026 /PRNewswire/ — Ideal Recovery, a St. Louis-based collateral recovery services... Read more.
Press Release for Early Warning Report Filing Pursuant to National Instrument 62-103
HALIFAX, NS, June 15, 2026 /CNW/ – Maritime Launch Services Inc. (Cboe CA: MAXQ) (OTCQB: MAXQF) (the “Company“) – This press release is... Read more.
Caristo Diagnostics Selected by World Economic Forum as a 2026 Technology Pioneer
Caristo’s flagship technology, CaRi-Heart, recognised for its groundbreaking ability to transform cardiovascular disease prevention and management Caristo... Read more.
ACTIVATE APPOINTS SCOTT SHULTZ AS CHIEF TECHNOLOGY OFFICER
WINNIPEG, MB, June 15, 2026 /PRNewswire/ — Activate, the world’s leading active gaming company and North America’s fastest-growing entertainment... Read more.
Los Angeles to contract with Verra Mobility launching the largest speed safety program in California
125 speed camera locations expected to be operational by the end of 2026 MESA, Ariz., June 15, 2026 /PRNewswire/ — Verra Mobility Corporation (NASDAQ: VRRM),... Read more.
Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
No filing review issues identified by FDA with PDUFA goal date set for April 14, 2027 If Approved, Ozekibart Would Be the First and Only FDA-Approved Treatment for... Read more.
LXT Launches Fully Integrated Self-Service Survey Platform Through clickworker
3-in-1 solution combines audience targeting, survey creation, and real-time reporting – with access to a global panel of 10 million contributors TORONTO, June... Read more.